跳至主要内容
临床试验/NCT03885570
NCT03885570Unknown不适用

Establishment of AI Prediction Model of Blood Transfusion Management in Patients With Mitral Valve Replacement

The Third Xiangya Hospital of Central South University1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2019年9月16日最近更新:
适应症

试验速览

阶段
不适用
入组人数
2,000
试验地点
1
主要终点
Intraoperative blood transfusion

研究概览

简要总结

The evaluation uses ΔHb as an independent factor combined with artificial intelligence (AI) to predict its impact on the prognosis and blood transfusion of patients undergoing cardiac surgery, thereby guiding perioperative clinical blood use and improving patient prognosis.

详细描述

  1. Select 8 hospitals to form a multi-center team, and enter the keyword "mitral valve replacement" in the case system of 8 hospitals to collect information on 2000 heart surgery patients.
  2. Mainly collect information on preoperative, intraoperative and postoperative test indexes (blood routine, liver and kidney function, coagulation function, blood gas), cardiac color Doppler, blood transfusion and prognosis of patients undergoing cardiac surgery, using statistical methods for analysis. Identify key observations.
  3. Gradually incorporate and exclude data, and use statistical methods to conduct preliminary analysis on the collected data.

The AI prediction model was established by machine learning algorithm to predict intraoperative blood transfusion, verify the specificity and sensitivity of the blood transfusion prediction model, and scientifically guide clinical blood use.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing "mitral valve replacement" surgery;
  • Age 18-75 years old;
  • 48h biochemical indicators before surgery, blood general indicators, coagulation indicators are complete.

排除标准

  • Lack of necessary tests and patient test information is not detailed, blood transfusion information is not detailed;
  • The blood transfusion information is not detailed in the same period as other cardiac operations (such as aortic valve surgery, coronary artery bypass grafting, etc.), but the tricuspid valvuloplasty is not ruled out at the same time;
  • Heart surgery or emergency surgery again.

结局指标

主要结局

Intraoperative blood transfusion

时间窗: through study completion, an average of 1 year

The amount of intraoperative blood component input

Mortality

时间窗: through study completion, an average of 2 year

The mortality during and after hospitalization

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验